Publications by authors named "Sabine Classen"

Claim this Profile
T
The IgG1 B-cell receptor provides survival and proliferative signals analogue to the Igα but not the Igβ co-receptor.
Jian Song, Nathalie Uyttersprot, Sabine Classen, Ari Waisman

Eur J Immunol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration.
Marc Beyer, Beatrix Schumak, Martin R Weihrauch, Bettina Andres, Thomas Giese, Sabine Classen

PLoS One· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.
Marc Beyer, Sabine Classen, Elmar Endl, Matthias Kochanek, Martin R Weihrauch

Clin Dev Immunol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation.
Marc Beyer, Yasser Thabet, Roman-Ulrich Müller, Timothy Sadlon, Sabine Classen

Nat Immunol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based gene expression signatures in non-small cell lung cancer.
Thomas Zander, Andrea Hofmann, Andrea Staratschek-Jox, Sabine Classen, Svenja Debey-Pascher

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar.
Manoj K Gupta, Damir J Illich, Andrea Gaarz, Matthias Matzkies, Filomain Nguemo, Sabine Classen

BMC Dev Biol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bead array-based microrna expression profiling of peripheral blood and the impact of different RNA isolation approaches.
Andrea Gaarz, Svenja Debey-Pascher, Sabine Classen, Daniela Eggle, Birgit Gathof

J Mol Diagn· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of T cell-based transcriptomics to identify three candidate biomarkers for monitoring anti-TGFbetaR therapy.
Sabine Classen, Christine Muth, Svenja Debey-Pascher, Daniela Eggle, Marc Beyer

Pharmacogenet Genomics· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
Luisa Klotz, Stephanie Hucke, Dominik Thimm, Sabine Classen, Andrea Gaarz

J Immunol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer vaccine enhanced, non-tumor-reactive CD8(+) T cells exhibit a distinct molecular program associated with "division arrest anergy".
Marc Beyer, Julia Karbach, Michael R Mallmann, Thomas Zander, Daniela Eggle, Sabine Classen

Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based transcriptomics: leukemias and beyond.
Andrea Staratschek-Jox, Sabine Classen, Andrea Gaarz, Svenja Debey-Pascher, Joachim L Schultze

Expert Rev Mol Diagn· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of genome-wide high-throughput technologies in biomarker development.
Sabine Classen, Andrea Staratschek-Jox, Joachim L Schultze

Biomark Med· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma.
Jens M Chemnitz, Daniela Eggle, Julia Driesen, Sabine Classen, James L Riley

Blood· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditions.
Sabine Classen, Thomas Zander, Daniela Eggle, Jens M Chemnitz, Benedikt Brors

J Immunol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta.
Ari Waisman, Manfred Kraus, Jane Seagal, Snigdha Ghosh, Doron Melamed, Sabine Classen

J Exp Med· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition.
Michael S von Bergwelt-Baildon, Alexey Popov, Tomo Saric, Jens Chemnitz, Sabine Classen

Blood· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma.
Marc Beyer, Matthias Kochanek, Thomas Giese, Elmar Endl, Martin R Weihrauch, Sabine Classen

Blood· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma.
Jens M Chemnitz, Julia Driesen, Sabine Classen, James L Riley, Svenja Debey

Cancer Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis